Last reviewed 2026-04-20 · How we verify

Chromium Cr 51 Edetate (chromium (51Cr) edetate)

Chromium Cr 51 Edetate (generic name: chromium (51Cr) edetate) is a chromium (51Cr) edetate drug. It is currently in unknown development.

Chromium (51Cr) edetate is a radiopharmaceutical that works by emitting radiation to diagnose or treat certain medical conditions.

Chromium (51Cr) edetate is a small molecule drug of the drug class chromium (51Cr) edetate. Its original development is attributed to an unknown entity, and its current ownership is also unknown. The target of this compound is not specified. It is not clear if it is FDA-approved or has any approved indications. The commercial status, including patent status and generic availability, is also unknown.

At a glance

Mechanism of action

Imagine your body as a city with many buildings. Chromium (51Cr) edetate is like a special kind of flashlight that helps doctors see inside the buildings (organs) to diagnose or treat problems. It emits a small amount of radiation that can be detected by special machines.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Chromium Cr 51 Edetate CI brief — competitive landscape report
• Chromium Cr 51 Edetate updates RSS · CI watch RSS
• portfolio CI

Frequently asked questions about Chromium Cr 51 Edetate

Related

• Drug class: All chromium (51Cr) edetate drugs
• Manufacturer: — full pipeline
• Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing